Education
About Us
Working with TipRanks
Follow Us
IGC Pharma (DE:IGS1)
FRANKFURT:IGS1
Earnings Data
Report Date
Jun 15, 2026TBA (Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
-0.02Last Year’s EPS
-0.02Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
DE:IGS1 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:IGS1 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 18, 2026 | €0.21 | €0.21 | 0.00% |
Nov 17, 2025 | €0.30 | €0.30 | +2.01% |
Aug 19, 2025 | €0.31 | €0.32 | +4.58% |
Jun 30, 2025 | €0.26 | €0.25 | -1.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does IGC Pharma (DE:IGS1) report earnings?
IGC Pharma (DE:IGS1) is schdueled to report earning on Jun 15, 2026, TBA (Confirmed).
What is IGC Pharma (DE:IGS1) earnings time?
IGC Pharma (DE:IGS1) earnings time is at Jun 15, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of IGC Pharma stock?
The P/E ratio of IGC Pharma is N/A.
What is DE:IGS1 EPS forecast?
DE:IGS1 EPS forecast for the fiscal quarter 2026 (Q4) is -0.02.